PDS Biotechnology Reports Clinical Data for Its Novel Immunotherapy PDS0101 in Follow up to Phase 1 Human Trial - BioSpace

PDS Biotechnology Reports Clinical Data for Its Novel Immunotherapy PDS0101 in Follow up to Phase 1 Human Trial  BioSpace

Comments

Post a Comment

Popular posts from this blog

Types of skin cancer and how to spot them - Jersey's Best

Image
If you learn only one thing about skin cancer, it should be this word: melanoma.   Melanoma is the equivalent of a budding terrorist hanging out with a bunch of high school pranksters. None of them is up to any good — but one of them is really, really dangerous.   If you suspect you may have melanoma, don't assume it will be like that growth your cousin had on his cheek from golfing so much. Just because he delayed seeing a doctor until he returned from summer vacation doesn't mean you have that luxury of time as well. You probably don't.   Melanoma is a five-alarm problem that demands immediate attention. Not a head-to-the-emergency-room crisis, but one necessitating an appointment with a doctor sooner rather than later.  When detected early, the five -year survival rate for melanoma is 99%.   The paradox of skin cancer is that the types causing the most cases result in the fewest number of deaths. Yet melanoma, which is far less common, accounts for the biggest numb...
Read more